ACP-204 in Adults With Alzheimer's Disease Psychosis

Recruiting

Phase 2

Phase 3

ACP-204 in Adults With Alzheimer's Disease PsychosisACP-204 in Adults With Alzheimer's Disease Psychosis

Sponsor:

ACADIA Pharmaceuticals Inc.

Code:

NCT06159673

Conditions

Alzheimer's Disease Psychosis

Eligibility Criteria

Sex: All

Age: 55 - 70+

Healthy Volunteers: Not accepted

Interventions

ACP-204

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-28. This information was provided to ClinicalTrials.gov by ACADIA Pharmaceuticals Inc. on 2025-03-25.